IP Library Granted Patent US 10,544,424
Granted Patent B2
US 10,544,424 · App. 15/130,866 · Granted Jan 28, 2020

Algal chloroplastic SRP54 mutants

Inventors: Christen G. DiPetrillo (San Diego, CA); Jay McCarren (Cardiff, CA); Leah Soriaga (San Diego, CA)
Assignee: Synthetic Genomics, Inc.
C12N15/8269C07K14/405C12N1/12C12N15/8218C12N15/8247C12P7/64
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,544,424
App. No.
15/130,866
Granted
Jan 28, 2020
Kind
B2
Abstract

Mutant photosynthetic microorganisms having reduced chlorophyll and increased photosynthetic efficiency are provided. The mutant strains have mutated chloroplastic SRP54 genes and exhibit increased productivity with respect to wild type strains. Also provided are mutant algal strains having mutated cytosolic SRP54 genes. Provided herein are methods of producing biomass and other products such as lipids using strains having mutations in an SRP54 gene. Also included are constructs and methods for attenuating or disrupting SRP54 genes.

Claims (18)

1. A recombinant or classically-derived Parachlorella LIHLA mutant having a mutated or attenuated gene encoding a chloroplastic signal recognition protein 54 (cpSRP54), wherein the mutant:

(a) exhibits at least a 20% reduction in chlorophyll under low light conditions;

(b) demonstrates a higher rate of carbon fixation on a per chlorophyll basis; and

(c) demonstrates greater biomass productivity,

with respect to a control alga of the same species.

2. An algal mutant according to claim 1 , wherein the mutant exhibits higher photosynthetic efficiency (Y(II)) at all physiologically relevant irradiances above 250 μE·m −2 ·s −1 with respect to a control alga of the same species.

3. An algal mutant according to claim 1 , wherein the mutant exhibits lower nonphotochemical quenching (NPQ) at all physiologically relevant irradiances above 250 μE·m −2 ·s −1 with respect to a control alga of the same species.

4. An algal mutant according to claim 1 , wherein the rate of oxygen evolution is higher than that of a control alga of the same species on a per chlorophyll basis.

5. An algal mutant according to claim 1 , wherein the mutant has been generated by UV irradiation, gamma irradiation, or chemical mutagenesis.

6. An algal mutant according to claim 1 , wherein the mutant is a genetically engineered mutant.

7. An algal mutant according to claim 6 , wherein the mutant has been genetically engineered by insertional mutagenesis, gene replacement, RNAi, antisense RNA, meganuclease genome engineering, one or more ribozymes, and/or a CRISPR/cas system.

8. An algal mutant according to claim 1 , wherein the cpSRP54 comprises an amino acid sequence having at least 90% identity to SEQ ID NO:15.

9. An algal biomass comprising an algal mutant according to claim 1 .

10. A method of producing an algal product, comprising culturing an algal mutant according to claim 1 and isolating at least one product from the culture.

11. A method according to claim 10 , wherein the product is algal biomass.

12. A method according to claim 10 , wherein the product is a lipid, a protein, a peptide, one or more amino acids, a carbohydrate, one or more nucleotides, a vitamin, a cofactor, a hormone, an antioxidant, or a pigment or colorant.

13. A method according to claim 10 , wherein the alga is cultured phototrophically.

14. An algal mutant according to claim 4 , wherein the rate of oxygen evolution is at least 50% higher than that of a control alga of the same species on a per chlorophyll basis.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2026
From: VIRIDOS, INC.
To: PHYKION INC.
Reel/Frame 073421/0601 →
SECURITY INTEREST Recorded Sep 13, 2024
From: VIRIDOS, INC.
To: BREAKTHROUGH ENERGY VENTURES II, L.P.
Reel/Frame 068589/0049 →
CHANGE OF NAME Recorded Apr 7, 2022
From: SYNTHETIC GENOMICS, INC.
To: VIRIDOS, INC.
Reel/Frame 059631/0684 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
SECURITY INTEREST Recorded Mar 20, 2019
From: SYNTHETIC GENOMICS, INC.
To: OXFORD FINANCE LLC
Reel/Frame 048655/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2016
From: DIPETRILLO, CHRISTEN G.; MCCARREN, JAY; SORIAGA, LEAH
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 039151/0224 →
Continuity (2)
Provisional Application 62148071 · Apr 15, 2015
Related Publication 20160304896A1 · Oct 20, 2016